Target intelligence / Profile preview

Claudin-10 (CLDN10)

Target
CLDN10
Molecular classification
Tight junction protein, Integral membrane protein, Paracellular ion channel
01

Overview

Claudin-10 is an integral membrane protein of the claudin family, primarily involved in forming tight junctions that regulate the paracellular passage of ions and solutes between epithelial and endothelial cells[3]. The protein has several alternatively spliced isoforms, the two most functionally significant being claudin-10a (primarily in the kidney cortex; forms selective anion channels) and claudin-10b (widely expressed; forms selective cation channels)[1][2]. Claudin-10 is essential for epithelial barrier integrity and plays specialized roles in renal electrolyte handling and organ-specific epithelial development, such as in tooth amelogenesis. Mutations in CLDN10 are causative for HELIX syndrome, characterized by hypohidrosis, electrolyte imbalance, and ectodermal defects including enamel hypoplasia, highlighting its importance in ion homeostasis and tissue differentiation[1]. Expression deregulation in tumors may have prognostic value, but direct drug targeting and corresponding therapy are not established to date[3].

Other names
Claudin-10CLDN10OSP-likeOSP-LCPETRL3Oligodendrocyte-specific protein-likeHELIXOSPLclaudin-10OSP-like proteinoligodendrocyte-specific protein-like
02

Mechanism of action

Not applicable (no approved targeting drugs); Claudin-10 modulates paracellular ion selectivity, and alterations primarily result from genetic mutations[1][2]

03

Biological functions

Paracellular ion transport (anion and cation selectivity depends on isoform)[1][2]Formation and regulation of tight junctions in epithelial and endothelial cells[3]Regulation of tissue barrier permeability and cell polarity[3]Epithelial differentiation and organ development (e.g., tooth/amelogenesis)[1]
04

Disease associations

HELIX syndrome (rare genetic disorder involving renal, exocrine gland, and skin manifestations)[1]Renal electrolyte transport disorders (e.g., hypocalcemia, hypermagnesemia, hyperphosphatemia)[1]Enamel defects/amelogenesis imperfecta[1]Hepatocellular carcinoma recurrence (prognostic association)[3]
05

Safety considerations

Alterations in Claudin-10 function or expression may lead to systemic electrolyte imbalance, impaired epithelial barrier function, and glandular dysfunction[1]No drug-related safety concerns established as there are no known pharmacologic agents directly targeting Claudin-10[3]
06

Interacting drugs

None specifically identified as approved or clinical drugs known to target Claudin-10 directly; no direct pharmacological modulator or inhibitor is clinically established[3]
07

Biomarkers

Mutational analysis of CLDN10 for HELIX syndrome and renal tubular disorders[1]Expression level in hepatocellular carcinoma as a prognostic marker for recurrence[3]

Beyond the preview

Go deeper on Claudin-10 (CLDN10).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Claudin-10 (CLDN10).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call